Loading
Yanuki
KEYWORD TOPIC
Novel Salmonella Vaccine Shows Promise in Clinical Trial | IO Biotech Stock (IOBT): Opinions on Phase 3 Clinical Trial Risks | Recursion Pharmaceuticals Begins Dosing in Early-Stage B-Cell Lymphoma Study | Groundbreaking ALS Treatment Shows Promising Results in Phase 2b Trial | Groundbreaking ALS Treatment Shows Significant Promise in Clinical Trial | Novel Salmonella Vaccine Shows Promise in Clinical Trial | IO Biotech Stock (IOBT): Opinions on Phase 3 Clinical Trial Risks | Recursion Pharmaceuticals Begins Dosing in Early-Stage B-Cell Lymphoma Study | Groundbreaking ALS Treatment Shows Promising Results in Phase 2b Trial | Groundbreaking ALS Treatment Shows Significant Promise in Clinical Trial

Health / Vaccines

Novel Salmonella Vaccine Shows Promise in Clinical Trial

A novel trivalent vaccine targeting typhoid fever and invasive non-typhoidal Salmonella (iNTS) infections has demonstrated promising safety and robust immune responses in a Phase 1 human trial. Developed by the University of Maryland and Bh...

A combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial
Novel Salmonella Vaccine Shows Promise in Clinical Trial Image via Nature
TOPIC clinical trial

Stocks / Biotech

IO Biotech Stock (IOBT): Opinions on Phase 3 Clinical Trial Risks

Recent online discussions regarding IO Biotech (IOBT) revolve around the high-stakes Phase 3 clinical trials and the company's financial stability. The outcome of these trials could significantly impact the stock price, with concerns raised...

IO Biotech Stock (IOBT) Opinions on Phase 3 Clinical Trial Risks

Health / Neurology

Groundbreaking ALS Treatment Shows Promising Results in Phase 2b Trial

Significant progress in the fight against Amyotrophic Lateral Sclerosis (ALS) has been reported. NeuroSense Therapeutics announced promising results from their Phase 2b PARADIGM trial for PrimeC, a novel treatment candidate. Analysis confir...

Health / Medical Research

Groundbreaking ALS Treatment Shows Significant Promise in Clinical Trial

Recent developments in Amyotrophic Lateral Sclerosis (ALS) research offer a glimmer of hope. News surrounding a potential treatment from NeuroSense Therapeutics indicates significant progress in combating this challenging neurodegenerative...